Platforms for the identification and validation of candidate small molecule treatments for TBCK Syndrome
Awardee: Jay Vivian
Institution: University of Kansas Medical Center
Award Amount: $50,600
Funding Period: February 1, 2021 - January 31, 2022
Previous
Previous
Osteoclasts and pain in Fibrous Dysplasia: investigating and targeting the molecular links in a transgenic mouse model (EF1α-GsαR201C mice) of human Fibrous Dysplasia
Next
Next